e-learning
resources
London 2016
Sunday, 04.09.2016
Inflammatory biomarkers in airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Eosinophilic inflammation amplifies the prednisolone-induced prothrombotic state in asthma
Christof J. Majoor (Baarn, Netherlands), Christof J. Majoor, Marlous S. Sneeboer, Anne de Kievit, Joost C.M. Meijers, Tom van der Poll, Rene Lutter, Pieter Willem Kamphuisen, Elisabeth H. Bel
Source:
International Congress 2016 – Inflammatory biomarkers in airway diseases
Session:
Inflammatory biomarkers in airway diseases
Session type:
Oral Presentation
Number:
493
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Christof J. Majoor (Baarn, Netherlands), Christof J. Majoor, Marlous S. Sneeboer, Anne de Kievit, Joost C.M. Meijers, Tom van der Poll, Rene Lutter, Pieter Willem Kamphuisen, Elisabeth H. Bel. Eosinophilic inflammation amplifies the prednisolone-induced prothrombotic state in asthma. Eur Respir J 2016; 48: Suppl. 60, 493
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Induced sputum lipid mediators in severe asthma
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016
Systemic inflammation, comorbidities and the outcome of adult-onset asthma
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
Implication of IL-18 in the chronic inflammation of severe refractory asthma
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Effect of systemic inflammation and multi-morbidity on outcome of adult-onset asthma
Source: International Congress 2016 – Asthma management
Year: 2016
Analysis of the inflammatory profile of children with controlled and uncontrolled severe asthma
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016
Markers of eosinophilic airway inflammation in patients with severe and mild to moderate asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Treating peripheral eosinophilia in asthma: Simple and effective
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Obesity influences inflammatory phenotype mainly in early onset severe asthmatics
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Features of inflammation in the asthma patients with osmotic airway hyperresponsiveness
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Coagulation activity increases with disease severity in patients with asthma
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
Distribution of sputum cellular phenotype in a large asthma cohort. Predicting factors for eosinophilic vs neutrophilic inflammation
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013
Late-onset hypereosinophilic asthma accompanied by systemic eosinophilic manifestations
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016
Effect of a 10-day oral corticosteroid course on hemostasis and inflammation in patients with stable asthma
Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD
Year: 2015
Interleukin-33 and Th2 cytokines correlate in acute asthma
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016
Modulation of inflammation by benralizumab in eosinophilic airway disease
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
Effect of roflumilast on airway remodeling in a murine model of chronic asthma
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015
Relation of hemogram parameters with asthma
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
Systemic cytokine signaling via IL-17 and its relation to clinical characteristics in children with asthma
Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers
Year: 2015
Systemic coagulation increases with asthma severity
Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept